Mark Mirochnick
- Virology top 0.5%
- HIV Research and Treatment 20
- Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment 58
- HIV/AIDS Research and Interventions 48
- Emergency Medicine top 0.5%
- HIV-related health complications and treatments 16
-
- Pharmacological Effects and Toxicity Studies 18
- Pharmaceutical studies and practices 6
- Obstetrics and Gynecology top 2%
-
- Pregnancy and Medication Impact 23
-
- Pneumocystis jirovecii pneumonia detection and treatment 7
- Co-authors
- Lynne MofensonMary Glenn FowlerLaura GuayPhilippa MusokeFrancis MmiroJ. Brooks JacksonThomas R. FlemingEdmund V. Capparelli
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (12 papers)AIDS (8 papers)Pediatric Research (7 papers)
- Partner nations
- United StatesThailandBrazil
In The Last Decade
Mark Mirochnick
84 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Virology 1.3k
- Infectious Diseases 2.9k
- Emergency Medicine 678
- Pediatrics, Perinatology and Child Health 824
- Obstetrics and Gynecology 243
Countries citing papers authored by Mark Mirochnick
This map shows the geographic impact of Mark Mirochnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Mirochnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Mirochnick more than expected).
Fields of papers citing papers by Mark Mirochnick
This network shows the impact of papers produced by Mark Mirochnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Mirochnick. The network helps show where Mark Mirochnick may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Mirochnick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 17 | |
| 6 | 2021 | 8 | |
| 7 | 2020 | 4 | |
| 8 | 2019 | 25 | |
| 9 | 2018 | 76 | |
| 10 | 2014 | 13 | |
| 11 | 2011 | 16 | |
| 12 | 2009 | 39 | |
| 13 | 2008 | 59 | |
| 14 | 2006 | 42 | |
| 15 | 2003 | 35 | |
| 16 | 2003 | 62 | |
| 17 | 2002 | 46 | |
| 18 | 1999 | 13 | |
| 19 | Qualitative amniotic fluid volume versus amniocentesis in predicting infection in preterm premature rupture of the membranes. | 1986 | 61 |
| 20 | Fetal biophysical profile versus amniocentesis in predicting infection in preterm premature rupture of the membranes. | 1986 | 41 |
About Mark Mirochnick
Mark Mirochnick is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 86 papers that have together received 3.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (58 papers), HIV/AIDS Research and Interventions (48 papers), Pregnancy and Medication Impact (23 papers), HIV Research and Treatment (20 papers), Pharmacological Effects and Toxicity Studies (18 papers), HIV-related health complications and treatments (16 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Pharmaceutical studies and practices (6 papers). The work is most often cited by research in Virology (1.3k citations), Infectious Diseases (2.9k citations) and Emergency Medicine (678 citations). Mark Mirochnick has collaborated with scholars based in United States, Thailand and Brazil. Frequent co-authors include Lynne Mofenson, Mary Glenn Fowler, Laura Guay, Philippa Musoke, Francis Mmiro, J. Brooks Jackson, Thomas R. Fleming, Edmund V. Capparelli, Brookie M. Best and Clemensia Nakabiito. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS, Pediatric Research, HIV Medicine and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.